Adverse Drug Reaction Classification System

         

ADR Ontology
ADR Term Urticaria
ADR ID BADD_A04469
ADR Hierarchy
10      Immune system disorders
10.01      Allergic conditions
10.01.06      Urticarias
10.01.06.001      Urticaria
23      Skin and subcutaneous tissue disorders
23.04      Angioedema and urticaria
23.04.02      Urticarias
23.04.02.001      Urticaria
Description A disorder characterized by an itchy skin eruption characterized by wheals with pale interiors and well-defined red margins. [CTCAE] A vascular reaction of the skin characterized by erythema and wheal formation due to localized increase of vascular permeability. The causative mechanism may be allergy, infection, or stress. [MeSH]
MedDRA Code 10046735
MeSH ID D014581
ADR Severity Grade (FAERS)
ADR Severity Grade (CTCAE)
Synonym
Acute allergic urticaria | Acute urticaria | Allergic urticaria | Erythema urticarial | Generalised urticarial | Generalised urticarial rash | Histamine-like rash | Hives | Nettle rash | Other specified urticaria | Pharmacological urticaria | Rash urticaria-like | Rash urticarial | Subcutaneous urticaria | Unspecified urticaria | Urticaria | Urticaria acute | Urticaria aggravated | Urticaria NOS | Urticaria subcutaneous | Urticaria, unspecified | Urticarial | Urticarial rash | Urticarial symptom | Urticated rash | Urtication | Welts | Wheals | Generalized urticaria | Urticaria generalised | Urticaria drug-induced | Urticaria localised | Urticaria localized | Generalized urticarial rash | Urticaria recurrent | Generalised urticaria | Atopic urticaria | Urticarias
Drugs Leading to the ADR
Drug IDDrug NameADR Frequency (FAERS)ADR Severity Grade (FAERS)
BADD_D02294Trimipramine--
BADD_D02295Trimipramine maleate--
BADD_D02297Triptorelin--
BADD_D02299Trisequens--
BADD_D02304Tropisetron--
BADD_D02305Trospium--
BADD_D02307Trovafloxacin--
BADD_D02308Trovafloxacin mesylate--
BADD_D02311Tuberculin purified protein derivative--
BADD_D02312Ulipristal0.000270%
BADD_D02314Umeclidinium0.000807%
BADD_D02319Urofollitropin--
BADD_D02320Urokinase--
BADD_D02321Ursodiol--
BADD_D02322Ustekinumab--
BADD_D02323Valacyclovir--
BADD_D02324Valacyclovir hydrochloride--
BADD_D02325Valdecoxib--
BADD_D02326Valganciclovir--
BADD_D02329Valproic acid--
BADD_D02331Valsartan0.001249%
BADD_D02332Vancomycin--
BADD_D02333Vancomycin hydrochloride--
BADD_D02337Varenicline--
BADD_D02338Varenicline tartrate--
BADD_D02339Vasopressin--
BADD_D02340Vasopressin tannate--
BADD_D02341Vecuronium bromide--
BADD_D02342Vedolizumab--
BADD_D02343Velaglucerase alfa--
The 42th Page    First    Pre   42 43 44 45    Next   Last    Total 45 Pages
ADReCS-Target
ADR Term Drug Name Target